Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers

NCT03852446 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Indoximod HCL (F2) tablets
DRUG: Indoximod base formulation
OTHER: Placebo
DRUG: Indoximod HCL (F2) tablets

Sponsor

NewLink Genetics Corporation